Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

INTRODUCTION: This open-label pilot study aimed to investigate the efficacy of canakinumab in colchicine-resistant familial Mediterranean fever (FMF) patients. METHOD: Patients with one or more attacks in a month in the preceding 3 months despite colchicine were eligible to enter a 30-day run-in per...

Descripción completa

Detalles Bibliográficos
Autores principales: Gül, Ahmet, Ozdogan, Huri, Erer, Burak, Ugurlu, Serdal, Kasapcopur, Ozgur, Davis, Nicole, Sevgi, Serhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559892/
https://www.ncbi.nlm.nih.gov/pubmed/26337145
http://dx.doi.org/10.1186/s13075-015-0765-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559892/
https://www.ncbi.nlm.nih.gov/pubmed/26337145
http://dx.doi.org/10.1186/s13075-015-0765-4

Ejemplares similares